| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 59220 | [[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt | 0.000100168541082771 | 0.46303752 |
| NSC 753221 | 3-Hydroxy-10-fluoro-5.6-dihydro-6-imino-isoindolo[2,1a]quinoxaline | 0.00012706483944704 | 0.21674517 |
| NSC 668254 | Null | 0.000209334878795459 | 0.26574498 |
| NSC 303861 | L-Cysteine analog | 0.000216242727122389 | 0.31654864 |
| NSC 351521 | Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) | 0.000216242727122389 | 0.36787676 |
| NSC 629229 | Null | 0.000216242727122389 | 0.03554739 |
| NSC 752464 | methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate | 0.000260156221906648 | 0.45655968 |
| NSC 4114 | Morpholinium-N-oxydiethylenedithiocarbamate | 0.000260156221906649 | 0.36619243 |
| NSC 208652 | 2,4-Quinazolinediamine, 5-chloro-6-[[(3,4-dichlorophenyl)amino]methyl]- | 0.000374267341249421 | 0.42259868 |
| NSC 695945 | Null | 0.000432107380838963 | 0.40235655 |